Novo Nordisk Shares Still Have a Long Road Back from 40% Slump
Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...
European shares at record peak as tech, healthcare lend support
European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...
Pharmaceutical Technology13h
RFK Jr. thrusts domestic manufacturing agenda on Day 2 of confirmation hearings
During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...
Opinion
The Eagle20hOpinion
Democrats should start with drug prices | Froma Harrop
President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
Jim Cramer on Novo Nordisk (NVO): ‘Be Careful’ Amid Trump Impact
Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ...
Sectors Up Close: 'Lots of competitors' to Novo Nordisk in healthcare stocks
Obesity drugs - especially Novo Nordic's Ozempic - dominated healthcare headlines in 2024, but Matt Miskin of John Hancock ...
KOB 44d
Stock market today: Asian markets are mixed after Wall Street edges back from its record
Shares are mixed in Asia after U.S. stocks edged back from their all-time high, with many regional markets closed for lunar ...